Drug Profile
Research programme: lytic bacterium cholesteatoma therapeutic - Microbial Robotics
Alternative Names: AuriBot™Latest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator Bacterial Robotics
- Developer Microbial Robotics
- Class Bacteria
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cholesteatoma
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for research development in Cholesteatoma in USA (Parenteral)
- 10 Oct 2014 Bacterial Robotics is now called Microbial Robotics
- 30 Jun 2014 Bacterial Robotics receives SBIR grant from the National Science Foundation for AuriBot™ development in Cholesteatoma